title: Alzheimer's Abeta40 studied by NMR at low pH reveals that sodium 4,4-dimethyl-4-silapentane-1-sulfonate (DSS) binds and promotes beta-ball oligomerization.
abstract: The Alzheimer's Abeta40 peptide forms soluble oligomers that are extremely potent neurotoxins and strongly impede synapses function. In this study the formation and structure of the large, soluble, neurotoxic Abeta40 oligomer called "beta-ball" were characterized by two-dimensional NMR, circular dichroism, fluorescence spectroscopy, hydrogen exchange, and equilibrium sedimentation. In acidic aqueous solution, half the Abeta40 molecules are in the beta-ball state; the remainder are monomeric. The equilibrium between the two states is slow as judged by NMR linewidths and is stable for months. The kinetics of beta-ball formation from monomer are biphasic with tau1 = 7 min and tau2 = 80 min with no transient helix formation. Monomeric Abeta40 is essentially devoid of stable secondary structure, although the central, Leu17-Ala21, and C-terminal, Gly29-Val40, hydrophobic regions show propensity toward adopting extended structure, and residues 22-25 tended to form a turn. We found that sodium 4,4-dimethyl-4-silapentane-1-sulfonate (DSS) binds to the central hydrophobic region of monomeric Abeta40. DSS binds beta-balls more strongly and caused them to double in size. Plausible micelle-like models for the beta-ball structure with and without bound DSS are presented.
authors.affiliation: Instituto de Química-Física "Rocasolano," Consejo Superior de Investigaciones Científicas, Serrano 119, 28006 Madrid, Spain.
authors.forename: Douglas V
authors.initials: DV
authors.lastname: Laurents
authors.forename: Paul M
authors.initials: PM
authors.lastname: Gorman
authors.forename: Meng
authors.initials: M
authors.lastname: Guo
authors.forename: Manuel
authors.initials: M
authors.lastname: Rico
authors.forename: Avijit
authors.initials: A
authors.lastname: Chakrabartty
authors.forename: Marta
authors.initials: M
authors.lastname: Bruix
mesh_terms: D017738:Alkanesulfonic Acids / Q000378:metabolism*; D000595:Amino Acid Sequence; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000378:metabolism* / Q000633:toxicity*; D000818:Animals; D002942:Circular Dichroism; D006801:Humans; D006859:Hydrogen / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008969:Molecular Sequence Data; D009474:Neurons / Q000187:drug effects*; D009498:Neurotoxins / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity; D019906:Nuclear Magnetic Resonance, Biomolecular; D017646:Organosilicon Compounds / Q000378:metabolism*; D016716:PC12 Cells; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism* / Q000633:toxicity*; D017433:Protein Structure, Secondary; D051381:Rats; D014297:Trimethylsilyl Compounds / Q000378:metabolism*
chemical_list: D017738:Alkanesulfonic Acids; D016229:Amyloid beta-Peptides; D009498:Neurotoxins; D017646:Organosilicon Compounds; D010446:Peptide Fragments; D014297:Trimethylsilyl Compounds; C078592:amyloid beta-protein (1-40); C009580:3-(trimethylsilyl)propanesulfonic acid; D006859:Hydrogen